Stereotactic body radiation therapy for hepatocellular carcinoma.

Stereotactic body radiation therapy for hepatocellular carcinoma. - Stereotactic body radiation therapy for hepatocellular carcinoma.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008502

Enrollment

200

Registered

2012-07-23

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) hypervascular HCC nodules, each up to 50 mm in diameter; (2) not suitable for the hepatic resection or ablative therapy; (3) Child-Turcotte-Pugh (CTP) score<7.

Exclusion criteria

Exclusion criteria: neighboring the Intestinal tract

Design outcomes

Primary

Measure	Time frame
Local tumor control rate, safety	—

Secondary

Measure	Time frame
overall survival rate, disease free survival rate	—

Countries

Japan

Contacts

Public ContactHiroshi Aikata

Hiroshima university Department of Medicine and Molecular Science

aikata@hiroshima-u.ac.jp082-257-5555

Outcome results